These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27557777)

  • 1. Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND.
    Obermeit LC; Beltran J; Casaletto KB; Franklin DR; Letendre S; Ellis R; Fennema-Notestine C; Vaida F; Collier AC; Marra CM; Clifford D; Gelman B; Sacktor N; Morgello S; Simpson D; McCutchan JA; Grant I; Heaton RK;
    J Neurovirol; 2017 Feb; 23(1):67-78. PubMed ID: 27557777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
    Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning.
    Blackstone K; Moore DJ; Heaton RK; Franklin DR; Woods SP; Clifford DB; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; Rivera-Mindt M; Deutsch R; Ellis RJ; Hampton Atkinson J; Grant I;
    J Int Neuropsychol Soc; 2012 Jan; 18(1):79-88. PubMed ID: 22114912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders.
    Tierney SM; Sheppard DP; Kordovski VM; Faytell MP; Avci G; Woods SP
    J Neurovirol; 2017 Jun; 23(3):404-421. PubMed ID: 28108972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance Between Self-Report and Performance-Based Measures of Everyday Functioning in HIV-Associated Neurocognitive Disorders.
    Shirazi TN; Summers AC; Smith BR; Steinbach SR; Kapetanovic S; Nath A; Snow J
    AIDS Behav; 2017 Jul; 21(7):2124-2134. PubMed ID: 28108876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caregiver versus self-reported activities of daily living among HIV-positive persons in Rakai, Uganda.
    Kisakye A; Saylor D; Sacktor N; Nakigozi G; Nakasujja N; Robertson K; Anok A; Wawer M; Gray R
    AIDS Care; 2019 Jul; 31(7):836-839. PubMed ID: 30554522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of the UCSD Performance-Based Skills Assessment-Brief (UPSA-B) in adults living with HIV: Associations with neuropsychological impairment and patient-reported everyday functioning difficulties.
    Moore RC; Paolillo EW; Heaton A; Fazeli PL; Jeste DV; Moore DJ
    PLoS One; 2017; 12(8):e0183614. PubMed ID: 28837678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and Correlates of Subjective Cognitive Impairment in HIV Disease.
    Sheppard DP; Woods SP; Massman PJ; Gilbert PE
    AIDS Behav; 2019 Mar; 23(3):617-626. PubMed ID: 30311103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-AIDS physical disability: data from the AIDS Time-Oriented Health Outcome Study.
    O'Dell MW; Hubert HB; Lubeck DP; O'Driscoll P
    Arch Phys Med Rehabil; 1998 Oct; 79(10):1200-5. PubMed ID: 9779671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.
    Anderson AM; Lennox JL; Nguyen ML; Waldrop-Valverde D; Tyor WR; Loring DW
    J Neurovirol; 2016 Dec; 22(6):816-822. PubMed ID: 27245594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates.
    Saloner R; Campbell LM; Serrano V; Montoya JL; Pasipanodya E; Paolillo EW; Franklin D; Ellis RJ; Letendre SL; Collier AC; Clifford DB; Gelman BB; Marra CM; McCutchan JA; Morgello S; Sacktor N; Jeste DV; Grant I; Heaton RK; Moore DJ;
    J Int Neuropsychol Soc; 2019 May; 25(5):507-519. PubMed ID: 30890191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the impact of cognitive impairment and disease severity on activities of daily living in MS patients with different disability levels.
    Yazgan YZ; Tarakcı E; Gungor F; Kurtuncu M
    Clin Neurol Neurosurg; 2021 Jan; 200():106398. PubMed ID: 33310534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting.
    Yechoor N; Towe SL; Robertson KR; Westreich D; Nakasujja N; Meade CS
    J Neurovirol; 2016 Dec; 22(6):808-815. PubMed ID: 27245592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A composite of multisystem injury and neurocognitive impairment in HIV infection: association with everyday functioning.
    Marquine MJ; Flores I; Kamat R; Johnson N; Umlauf A; Letendre S; Jeste D; Grant I; Moore D; Heaton RK
    J Neurovirol; 2018 Oct; 24(5):549-556. PubMed ID: 29777462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.
    Dampier W; Antell GC; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; James T; Devlin KN; Giovannetti T; Libon DJ; Szep Z; Ehrlich GD; Wigdahl B; Krebs FC
    J Neurovirol; 2017 Feb; 23(1):113-124. PubMed ID: 27400931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-individual neurocognitive variability confers risk of dependence in activities of daily living among HIV-seropositive individuals without HIV-associated neurocognitive disorders.
    Morgan EE; Woods SP; Grant I;
    Arch Clin Neuropsychol; 2012 May; 27(3):293-303. PubMed ID: 22337933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficient Emotion Processing is Associated with Everyday Functioning Capacity in HIV-associated Neurocognitive Disorder.
    Grabyan JM; Morgan EE; Cameron MV; Villalobos J; Grant I; Paul Woods S;
    Arch Clin Neuropsychol; 2018 Mar; 33(2):184-193. PubMed ID: 28655206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults.
    Cysique LA; Dermody N; Carr A; Brew BJ; Teesson M
    J Neurovirol; 2016 Feb; 22(1):56-65. PubMed ID: 26304840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.
    Kamminga J; Bloch M; Vincent T; Carberry A; Brew BJ; Cysique LA
    J Clin Exp Neuropsychol; 2017 Oct; 39(8):753-767. PubMed ID: 28052738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder.
    Rosenthal LS; Skolasky RL; Moxley RT; Roosa HV; Selnes OA; Eschman A; McArthur JC; Sacktor N
    J Neurovirol; 2013 Oct; 19(5):432-41. PubMed ID: 24081883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.